Original Research

Published on 01 Nov 2024

Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers

in Pharmacology of Anti-Cancer Drugs

Jun Wu
Jinghua Lu
Qiuyue Chen
Haojie Chen
Yongqiang Zheng
Minggang Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494131

261 views

Original Research

Published on 01 Nov 2024

Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles

in Pharmacology of Anti-Cancer Drugs

Fei Shen
Yun-Sheng Zheng
Lan Dong
Ziyang Cao
Jie Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500731

247 views

Original Research

Published on 01 Nov 2024

Transcriptome analysis revealed the genes and major pathways involved in prunetrin treated hepatocellular carcinoma cells

in Pharmacology of Anti-Cancer Drugs

Abuyaseer Abusaliya
Hun Hwan Kim
Preethi Vetrivel
Pritam Bhagwan Bhosale
Se Hyo Jeong
Min Yeong Park
Si Joon Lee
Gon Sup Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400186

219 views

Review

Published on 01 Nov 2024

Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy

in Pharmacology of Anti-Cancer Drugs

Qian Li
Yan Tong
Jianxiang Chen
Tian Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491802

198 views

Original Research

Published on 30 Oct 2024

Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system

in Pharmacology of Anti-Cancer Drugs

Yifeng Bai
Xiaomei Wang
Xiaoqin Dai
Qinghua Ma
Honglin Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1398667

210 views

Editorial

Published on 30 Oct 2024

Editorial: Novel anti-cancer agents targeting tumour metastasis and stemness

in Pharmacology of Anti-Cancer Drugs

Luping Pang
Bo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504024

182 views

Review

Published on 30 Oct 2024

The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies

in Pharmacology of Anti-Cancer Drugs

Haitao Wang
Rui Tang
Ling Jiang
Yingtian Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494802

242 views

Mini Review

Accepted on 28 Oct 2024

Cellular components of tumor microenvironment: understanding their role in lymphatic metastasis of tumors

in Pharmacology of Anti-Cancer Drugs

Ziyi Wang
Zehui Li
Xiangyu Sun
Yan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463538

Original Research

Published on 28 Oct 2024

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Yuanqiong Duan
Ying Wang
Shentao Lu
Mei Zeng
Lubin Liu
Qian Dai
Rutie Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448144

311 views

Original Research

Accepted on 25 Oct 2024

Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells

in Pharmacology of Anti-Cancer Drugs

Fen Hu
Yuxi Sun
Yunfeng Zhang
Jiaxin Chen
Yingzi Deng
Yifei Li
Ruobing Li
Zhang Juan
Yongping Liang
Yan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453447

115 views

Review

Published on 25 Oct 2024

Anti-tumor mechanism of artesunate

in Pharmacology of Anti-Cancer Drugs

Xiaoyu Fan
Yiming Yan
Yafei Li
Yu Song
Bo Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1483049

335 views

Case Report

Published on 24 Oct 2024

The addition of PD-1 inhibitor overcame trastuzumab resistance in patients with HER2 positive, PD-L1 negative metastatic gastric cancer: Case report and review of literature

in Pharmacology of Anti-Cancer Drugs

Zhenpeng Wen
Daoli Ye
Qiancheng Hu
Hongfeng Gou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447140

164 views

Review

Published on 24 Oct 2024

Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers

in Pharmacology of Anti-Cancer Drugs

Shizong Wang
Yang Bai
Jie Ma
Liang Qiao
Mingqing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442227

154 views

Original Research

Accepted on 23 Oct 2024

Impact of Camel Milk Lactoferrin Peptides Against Breast Cancer Cells: In silico and In vitro Study

in Pharmacology of Anti-Cancer Drugs

Othman A. Baothman
Ehab Ali
Hassan Alguridi
Salman Hosawi
Emad Konozy
Isam Abu Zeid
Abrar Ahmad
Hisham N Altayb

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1425504

155 views

Review

Accepted on 23 Oct 2024

MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters

in Pharmacology of Anti-Cancer Drugs

Jin Hongxu
Lu Xin-Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486783

Original Research

Published on 23 Oct 2024

Synergistic effects of anlotinib and DDP on breast cancer: targeting the VEGF/JAK2/STAT3 axis

in Pharmacology of Anti-Cancer Drugs

Hongmei Zhang
Chunling Liu
Ye Jin
Zheng Wang
Yi Guan
Zhenxian Jia
Tong Cui
Zhi Zhang
Xuemei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494265

1,062 views

Navigation group

Articles

Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers

Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles

Transcriptome analysis revealed the genes and major pathways involved in prunetrin treated hepatocellular carcinoma cells

Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy

Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system

Editorial: Novel anti-cancer agents targeting tumour metastasis and stemness

The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies

Cellular components of tumor microenvironment: understanding their role in lymphatic metastasis of tumors

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis

Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells

Anti-tumor mechanism of artesunate

The addition of PD-1 inhibitor overcame trastuzumab resistance in patients with HER2 positive, PD-L1 negative metastatic gastric cancer: Case report and review of literature

Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers

Impact of Camel Milk Lactoferrin Peptides Against Breast Cancer Cells: In silico and In vitro Study

MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters

Synergistic effects of anlotinib and DDP on breast cancer: targeting the VEGF/JAK2/STAT3 axis